2-174748734-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_000079.4(CHRNA1):c.1088C>G(p.Thr363Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T363I) has been classified as Uncertain significance.
Frequency
Consequence
NM_000079.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 1AInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- lethal multiple pterygium syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
- myasthenic syndrome, congenital, 1B, fast-channelInheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000079.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CHRNA1 | NM_000079.4 | MANE Select | c.1088C>G | p.Thr363Arg | missense | Exon 8 of 9 | NP_000070.1 | ||
| CHRNA1 | NM_001039523.3 | c.1163C>G | p.Thr388Arg | missense | Exon 9 of 10 | NP_001034612.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CHRNA1 | ENST00000348749.9 | TSL:1 MANE Select | c.1088C>G | p.Thr363Arg | missense | Exon 8 of 9 | ENSP00000261008.5 | ||
| ENSG00000236449 | ENST00000442996.1 | TSL:1 | n.321+18910G>C | intron | N/A | ||||
| CHRNA1 | ENST00000261007.9 | TSL:2 | c.1163C>G | p.Thr388Arg | missense | Exon 9 of 10 | ENSP00000261007.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1088C>G (p.T363R) alteration is located in exon 8 (coding exon 8) of the CHRNA1 gene. This alteration results from a C to G substitution at nucleotide position 1088, causing the threonine (T) at amino acid position 363 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Lethal multiple pterygium syndrome Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 363 of the CHRNA1 protein (p.Thr363Arg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CHRNA1-related conditions. ClinVar contains an entry for this variant (Variation ID: 568875). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CHRNA1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at